Therapy with hydrochlorothiazide and spironlactone decreases the risk of calcium oxalate precipitation in premature infants

Authors

Thomas Campfield MD, Baystate HealthFollow
Gary Rockwell MD, Baystate HealthFollow
Gregory Braden MD, Baystate HealthFollow

Author Department

Medicine; Pediatrics

Document Type

Presentations, Research

Publication Date

5-1-2010

Recommended Citation

Rockwell G, Eaton L, Klein D, Braden G, Campfield T. Therapy with hydrochlorothiazide and spironlactone decreases the risk of calcium oxalate precipitation in premature infants. Society for Pediatric Research Annual Meeting. Vancouver, Canada. May 1-May 4, 2010.